pylclari
curium pet france - piflufolastat (18f) - prostate neoplasme - produse radiofarmaceutice de diagnosticare - acest medicament este destinat exclusiv diagnosticului. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
da-bone 70 mg/5600 ui
teva pharm. works private ltd. company - ungaria - acid alendronicum+colecalciferolum - compr. - 70mg/5600ui - med. ce influenteaza in structura osoasa si mineralizare bifosfonati in combinatii
cupidon-farm comprimate 35 mg
farmaco sa, im - sildenafilum - comprimate - 35 mg
cupidon-farm comprimate 70 mg
farmaco sa, im - sildenafilum - comprimate - 70 mg
sandimmun neoral 100 mg capsule moi
novartis pharma ag - cyclosporinum - capsule moi - 100 mg
sandimmun neoral 25 mg capsule moi
novartis pharma ag - cyclosporinum - capsule moi - 25 mg
sandimmun neoral 50 mg capsule moi
novartis pharma ag - cyclosporinum - capsule moi - 50 mg
wobenzym comprimate gastrorezistente
mucos pharma gmbh&co.kg - o combinatie - comprimate gastrorezistente
ceftriaxon pulbere pentru solutie injectabila 0,5 g
kievmedpreparat sap - ceftriaxonum - pulbere pentru solutie injectabila - 0,5 g
chlorophyllin-oz comprimate de supt 12,5 mg
gntls srl, uzina experimentala - extractul de frunze de eucalipții - comprimate de supt - 12,5 mg